About Hospital of the Uni of Pennsylvania; Section of Hematology/Oncology
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Hospital of the Uni of Pennsylvania; Section of Hematology/Oncology
During the past decade, Hospital of the Uni of Pennsylvania; Section of Hematology/Oncology conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Empagliflozin Add on to Linagliptin Study in Japanese Patient With Type 2 Diabetes Mellitus
2015-05-14
2017-03-27
Completed
275
Linagliptin as Add on Therapy to Empagliflozin 10 mg or 25 mg With Japanese Patients With Type 2 Diabetes Mellitus
2015-05-12
2017-06-16
Completed
880
Long-term Safety and Efficacy of Empagliflozin as Add on to GLP-1 RA
2015-10-29
2017-06-02
Completed
65
A Study of Tirzepatide (LY3298176) Compared to Dulaglutide in Participants With Type 2 Diabetes
2019-05-07
2021-03-31
Completed
636
Phase II / III Study of COVID-19 DNA Vaccine (AG0302-COVID19)
2020-11-23
2022-02-01
Completed
500
A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Who Have Obesity or Are Overweight
2021-03-29
2023-04-10
Completed
938
A Study to Evaluate the Efficacy and Safety of PF-06882961 in Adults With Obesity
2021-01-29
2023-10-17
Active, not recruiting
627
A Study of Two Doses of Dulaglutide (LY2189265) in Japanese Patients With Type 2 Diabetes
2021-04-13
2023-04-29
Active, not recruiting
585
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Hospital of the Uni of Pennsylvania; Section of Hematology/Oncology
According to Clinical.Site data, the most researched conditions in "Hospital of the Uni of Pennsylvania; Section of Hematology/Oncology" are
"Colorectal Cancer" (1 trials) and "Malignant Melanoma" (1 trials). Many other conditions were trialed in "Hospital of the Uni of Pennsylvania; Section of Hematology/Oncology" in a lesser frequency.
Clinical Trials Intervention Types at Hospital of the Uni of Pennsylvania; Section of Hematology/Oncology
Most popular intervention types in "Hospital of the Uni of Pennsylvania; Section of Hematology/Oncology" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "5-Fluorouracil (5-FU)" (1 trials), "Capecitabine" (1 trials), "Leucovorin (LV)" (1 trials), "Oxaliplatin" (1 trials) and "vemurafenib" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Hospital of the Uni of Pennsylvania; Section of Hematology/Oncology
The vast majority of trials in "Hospital of the Uni of Pennsylvania; Section of Hematology/Oncology" are
2 trials for "All" genders.
Clinical Trials Status at Hospital of the Uni of Pennsylvania; Section of Hematology/Oncology
Currently, there are NaN active trials in "Hospital of the Uni of Pennsylvania; Section of Hematology/Oncology".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Hospital of the Uni of Pennsylvania; Section of Hematology/Oncology,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Hospital of the Uni of Pennsylvania; Section of Hematology/Oncology, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".